Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

NCT05633420 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Pyramax

Sponsor

Shin Poong Pharmaceutical Co. Ltd.